FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
about
Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27 450 Participants
P2860
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
FGF-23 and Osteoprotegerin but ...... nic kidney disease stages 3-5.
@en
type
label
FGF-23 and Osteoprotegerin but ...... nic kidney disease stages 3-5.
@en
prefLabel
FGF-23 and Osteoprotegerin but ...... nic kidney disease stages 3-5.
@en
P2093
P2860
P356
P1433
P1476
FGF-23 and Osteoprotegerin but ...... nic kidney disease stages 3-5.
@en
P2093
Anders Larsson
Helen V Alderson
James P Ritchie
Philip A Kalra
Rachel Middleton
Tobias E Larsson
P2860
P304
P356
10.1111/NEP.12664
P577
2016-07-01T00:00:00Z